Scotts Miracle-Gro (SMG) Files Form 144 for 11,297-Share Sale

Rhea-AI Filing Summary

The Scotts Miracle-Gro Company (SMG) Form 144 notifies the market of a proposed sale of 11,297 common shares, with an aggregate market value of $681,302.71, intended for sale on the NYSE on or about 09/10/2025. The filing identifies the broker as Merrill and reports total shares outstanding of 57,738,577. The securities to be sold were acquired through restricted stock vesting on various dates between 2019 and 2023 from Scotts Miracle-Gro. The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.

Positive

• Full disclosure filed: A Form 144 was submitted identifying the broker, number of shares, market value, sale date, and shares outstanding.
• Securities sourced from restricted stock vesting: All listed shares were acquired via restricted stock vest events from Scotts Miracle-Gro between 2019 and 2023.
• No recent sales reported: The filer states "Nothing to Report" for securities sold in the past three months, indicating no recent disposals.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing an insider sale of vested restricted shares; size is small relative to outstanding shares.

The filing reports a proposed sale of 11,297 common shares valued at $681,302.71. With 57,738,577 shares outstanding reported in the form, the proposed sale represents roughly 0.02% of outstanding common shares, indicating limited market impact. All holdings listed were acquired via restricted stock vesting from the issuer between 2019 and 2023, and the filer reports no sales in the past three months. This is consistent with an insider liquidity event rather than a change in control or material corporate development.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 notice requirements; documentation of vested restricted shares and broker involvement is clear.

The form provides required disclosure of the source of the securities (restricted stock vesting) and names the executing broker. The signature/representation language confirms the filer asserts no undisclosed material adverse information. There are no indications in the filing of accelerated vesting, related-party transfers, or concurrent significant dispositions that would raise governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	11297	681302.71	57738577	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/02/2021	Restricted stock vest	Scotts Miracle Gro			2682	02/02/2021	na
common	02/04/2022	restricted stock vest	Scotts Miracle Gro			3160	02/04/2022	na
Common	01/30/2020	Restricted stock vest	Scotts Miracle Gro			2548	01/30/2020	na
common	02/03/2023	restrictd stock vest	Scotts Miracle Gro			1960	02/03/2023	na
common	02/06/2023	restricted stock vest	Scotts Miracle Gro			350	02/06/2023	na
common	01/29/2019	restricted stock vest	Scotts Miracle Gro			244	01/29/2019	na
common	04/01/2023	restricted stock vest	Scotts Miracle Gro			353	04/01/2023	na

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the SMG Form 144 announce?

The filing announces a proposed sale of 11,297 common shares of SMG with a total market value of $681,302.71, proposed to be sold on 09/10/2025 on the NYSE.

Who is the broker handling the proposed sale in the SMG Form 144?

The broker named in the filing is Merrill with an address listed in Columbus, Ohio.

How were the securities to be sold acquired according to the filing?

The securities were acquired through restricted stock vesting on various dates between 01/29/2019 and 04/01/2023, from Scotts Miracle-Gro.

Does the Form 144 report any sales by the filer in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What percentage of outstanding shares does the proposed sale represent?

Based on the filing's numbers (11,297 shares and 57,738,577 outstanding), the proposed sale represents approximately 0.02% of outstanding common shares.